China’s fast growing healthcare market represents a significant opportunity for pharmaceutical and biotechnology companies to develop and launch therapies. By capitalizing on local research, development, manufacturing, and regulatory know-how, companies can design and execute effective China strategies as a platform for China and global registration. Navigating local regulatory systems from preclinical through registration can seem complex and pose significant hurdles. In this complimentary live webinar open to life science professionals globally, WuXi brings together key thought leaders and players to discuss effective paths to bringing safe and effective therapies to China market.
Round Table Discussions with
Jerome Zeldis, Chief Medical Officer, Celgene Corp. and CEO, Celgene Global Health RuiPing Dong, Senior Vice President, Head of Emerging Markets R&D, Merck. Kent Thoelke, Executive Vice President, Scientific & Medical Affairs, PRA International Moderated by Richard Soll, Senior Vice President of Integrated Services and Head of Corporate Alliances, WuXi AppTec
Event Date: Webinar | June 13, 2013 Time: 8:00am-9:00am PDT, 11:00am-12:00pm EDT, 15:00-16:00 GMT Registration: Complimentary live webcast open to life science professionals globally